TNM classification of breast cancer: Changes and comments on the 7th edition;TNM-klassifikation beim mammakarzinom: Neuerungen und anmerkungen zur 7. auflage

Pathologe

Volumn 31, Issue 5, 2010, Pages 361-366

  Sinn, H P ^a   Helmchen, B ^b   Wittekind, C H ^c  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b TRIEMLI HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Breast cancer; Micrometastases; Sentinel lymph nodes; Tumor staging

Indexed keywords

ARTICLE; BREAST; BREAST TUMOR; CANCER INVASION; CANCER STAGING; CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; LUNG CARCINOMA; LYMPH NODE METASTASIS; METHODOLOGY; NIPPLE; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NIPPLES; PAGET'S DISEASE, MAMMARY; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 77957572836     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-010-1307-0     Document Type: Article

References (26)

1. American Joint Committee on Cancer (2010) AJCC cancer staging manual. Springer, New York London
2. Anderson W, Chu K, Chang S (2003) Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities? J Clin Oncol 21:2254-2259
3. Carey L, Metzger R, Dees E et al (2005) American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome. J Natl Cancer Inst 97:1137-1142
4. Chen S, Hoehne F, Giuliano A (2007) The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol 14:3378-3384
5. Cserni G (1999) The reliability of sampling three to six nodes for staging breast cancer. J Clin Pathol 52:681-683
6. Deutsche Krebsgesellschaft (2008) Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Zuckschwerdt, München
7. Fisher E (1997) Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast. CA Cancer J Clin 47:52-64
8. Foroudi F, Tiver K (2000) Occult breast carcinoma presenting as axillary metastases. Int J Radiat Oncol Biol Phys 47:143-147
9. Goldhirsch A, Ingle J, Gelber R et al (2009) Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 20:1319-1329
10. Güth U, Huang D, Schötzau A et al (2010) Breast cancer with non-inflammatory skin involvement: current data on an underreported entity and its problematic classification. Breast 19:59-64
11. Harmer M, Denoix P, Hamperl H (1968) Das TNM-System zur Klassifikation von Tumorkrankheiten. Klin Wochenschr 46:1181-1185
12. Harms K, Wittekind C (2009) Prognosis of women with pT4b breast cancer: the significance of this category in the TNM system. Eur J Surg Oncol 35:38-42
13. Holland R, Hendriks JH, Vebeek Al et al (1990) Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 335:519-522
14. Hübner G, Bokemeyer C (2005) CUP-Syndrom - Tumorerkrankung mit unbekanntem Primärtumor. DGHO Leitlinie
15. International Union against Cancer (1959) Clinical stage classification for malignant tumours of the breast. Br J Surg 47:330-332
16. International Union against Cancer (1959) Clinical stage classification. Malignant tumours of the breast. 1960-1964. Br J Radiol 32:824-826
17. Kreipe H, Sinn HP (2009) Pathologie. In: AGO-Organkommission-Mamma (Hrsg) Aktuelle Empfehlungen zur Therapie primärer und fortgeschrittener Mammakarzinome. Zuckschwerdt, München
18. Lester S, Bose S, Chen Y et al (2009) Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med 133:1515-1538
19. Perry N, Broeders M, Wolf CD (2006) European guidelines for quality assurance in breast cancer screening and diagnosis. European Commission, Luxembourg
20. Sahoo S, Lester S (2009) Pathology of breast carcinomas after neoadjuvant chemotherapy: an overview with recommendations on specimen processing and reporting. Arch Pathol Lab Med 133:633-642
21. Schnitt S (1998) Microinvasive carcinoma of the breast: a diagnosis in search of a definition. Adv Anat Pathol 5:367-372
22. Turner R, Weaver D, Cserni G et al. (2008) Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. J Clin Oncol 26:258-263
23. Wittekind C, Meyer HJ, UICC (Hrsg) (2010) TNM: Klassifikation maligner Tumoren, 7. Aufl. Wiley-VCH, Weinheim
24. Vlastos G, Jean M, Mirza A et al (2001) Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol 8:425-431
25. Wieland A, Louwman M, Voogd A et al (2004) Determinants of prognosis in breast cancer patients with tumor involvement of the skin (pT4b). Breast J 10:123-128
26. Woodward W, Cristofanilli M (2009) Inflammatory breast cancer. Semin Radiat Oncol 19:256-265